Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
Niktimvo (axatilimab-csfr)
i
Other names:
SNDX-6352, UCB 6352, UCB6352, SNDX 6352, INCA34176, INCA034176, INCA-034176, SNDX6352, UCB-6352
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Incyte, Royalty, Syndax Pharma, UCB
Drug class:
CSF-1R inhibitor
Related drugs:
‹
avapritinib (13)
TPX-0022 (8)
pexidartinib (6)
pacritinib (3)
HX301 (2)
vorolanib (1)
OPN-7486 (1)
BMS-986227 (1)
CS 2164 (1)
ABSK021 (1)
AMB-05X (0)
C019199 (0)
HH185 (0)
LY3022855 (0)
NMS-088 (0)
SU 14813 (0)
SYHA1813 (0)
Q702 (0)
SYHA1817 (0)
BLZ-945 (0)
DCC-3014 (0)
avapritinib (13)
TPX-0022 (8)
pexidartinib (6)
pacritinib (3)
HX301 (2)
vorolanib (1)
OPN-7486 (1)
BMS-986227 (1)
CS 2164 (1)
ABSK021 (1)
AMB-05X (0)
C019199 (0)
HH185 (0)
LY3022855 (0)
NMS-088 (0)
SU 14813 (0)
SYHA1813 (0)
Q702 (0)
SYHA1817 (0)
BLZ-945 (0)
DCC-3014 (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login